We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Universitaire Ziekenhuizen Leuven.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01267591
First Posted: December 28, 2010
Last Update Posted: December 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Universitaire Ziekenhuizen Leuven
  Purpose

Background: The reactive hyperemia-peripheral artery tonometry (RH-PAT) is a newly developed method for noninvasive endothelial function assessment.

Objective: The goal of this study is to determine whether a significant difference in RH-PAT score is present between adolescents with type 1 diabetes (T1D) in comparison with controls. We will also compare RH-PAT scores in obese adolescents versus controls.


Condition
Peripheral Artery Tonometry Diabetes Children Obesity

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children.

Resource links provided by NLM:


Further study details as provided by Universitaire Ziekenhuizen Leuven:

Primary Outcome Measures:
  • RHPAT [ Time Frame: 2 years ]

Estimated Enrollment: 70
Study Start Date: January 2009
Groups/Cohorts
control
type 1 diabetes
obesity

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
children seen at consultation in University Hospital
Criteria

Inclusion Criteria:

  • 12-19 years of age

Exclusion Criteria:

  • type 2 diabetes; obesity in group of type 1 diabetes
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01267591


Contacts
Contact: kristina casteels, MD Phd 00-32-16-343801

Locations
Belgium
University Hospital Leuven Recruiting
Leuven, Belgium
Contact: kristina casteels, MD PhD    00-32-16-343801      
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: kristina casteels, Pediatrie, UZLeuven
ClinicalTrials.gov Identifier: NCT01267591     History of Changes
Other Study ID Numbers: UZLeuven
First Submitted: December 27, 2010
First Posted: December 28, 2010
Last Update Posted: December 28, 2010
Last Verified: January 2009

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases